endometriosis, infertility, endometriosis-associated infertility, anti-Mullerian hormone, follicle-stimulating hormone, luteinizing hormone, testosterone, prolactin, estradiol, progesterone, assisted reproductive technologies, stimulation protocol


Introduction. Endometriosis is an estrogen-dependent chronic inflammatory disease that causes endometriosis-associated infertility in approximately 30–50 % of women with a confirmed case.

The aim of the study – to analyze the reproductive hormonal panel of patients with endometriosis-associated infertility to choose the optimal ovulation stimulation protocol in the programs of assisted reproductive technologies.

Research Methods. In accordance with the purpose, a comparative retrospective analysis of the results of the hormonal panel was carried out in 116 women with infertility on the background of endometriosis with long and short ovulation stimulation protocols and a control group in the programs of assisted reproductive technologies. Patients were divided into 3 groups. Group 1 consisted of 44 women with endometriosis-associated infertility who underwent controlled ovarian stimulation according to a long protocol with a-GnRH. Group 2 consisted of 42 patients with endometriosis-associated infertility who underwent controlled ovarian stimulation according to a short protocol with anti-GnRH. Comparison group 3 (control) consisted of 30 women with tubal factor infertility. The level of anti-Mullerian hormones (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, estradiol E2, and total testosterone in blood serum was determined by the enzyme-linked immunosorbent assay (ELISA) method in the laboratory of the Medical Center “Clinic of Professor Stefan Khmil” (accreditation No. 268604/2019). Indicators of the listed hormones were determined on certain days of the menstrual cycle. The level of total testosterone, follicle-stimulating, luteinizing hormone, estradiol was determined on the day 2–3 of the cycle, the level of progesterone was determined on the day 21–22 of the cycle, and on the day of the trigger injection the level of estradiol and progesterone was determined. The level of all the listed hormones was determined by the immunoenzyme analyzer “StatFax” and the test system “Diagnostic Systems Laboratories, Inc.” (USA).

Results and Discussion. A certain regularity of the hormonal panel of women with endometriosis-associated infertility was established, in particular, an increased level of FSH, an increased level of LH, a decreased ratio of LH to FSH, decreased anti-Mullerian hormone, which correlated with the degree of prevalence of the process, progesterone and androgen deficiency. However, the hyperestrogenic state inherent in endometriosis has been found to directly contribute to lesion growth through its proliferative and inflammatory effects on endometrial tissue.

Conclusions. Endometriosis-associated infertility is caused by a malfunction of the hypothalamic-pituitary-ovarian system, which requires more detailed further study in order to develop new technologies and treatment protocols. Undoubtedly, the best method of treating endometriosis associated infertility is the use of assisted reproductive technologies, however, patient management tactics and the stimulation protocol must be selected individually for each individual case of the diagnosis, depending on the reproductive potential (ovulatory reserve, hormonal profile) and the woman's history.


Benagiano, G., Brosens, I., Lippi, D. (2014). The history of endometriosis. Gynecol. Obstet. Invest., 78 (1), 1-9. DOI: 10.1159/000358919. Epub 2014 May 16. PMID: 24853333

Bulun, S.E., Yilmaz, B.D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., Wei, J. (2019). Endometriosis. Endocr. Rev., 40 (4), 1048-1079. DOI: 10.1210/er.2018-00242. PMID: 30994890; PMCID: PMC6693056

Taylor, H.S., Kotlyar, A.M., Flores, V.A. (2021). Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet, 397 (10276), 839-852. DOI: 10.1016/S0140-6736(21)00389-5. PMID: 33640070

Kiesel, L., Sourouni, M. (2019). Diagnosis of endometriosis in the 21st century. Climacteric., 22 (3), 296-302. DOI: 10.1080/13697137.2019.1578743. Epub 2019 Mar 25. PMID: 30905186

Saunders, P.T.K., Horne, A.W. (2021). Endo­met­riosis: Etiology, pathobiology, and therapeutic prospects. Cell., 184 (11), 2807-2824. DOI: 10.1016/j.cell.2021.04.041. PMID: 34048704

Macer, M.L., Taylor, H.S. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet. Gynecol. Clin. North Am., 39 (4), 535-549. DOI: 10.1016/j.ogc.2012. 10.002. PMID: 23182559; PMCID: PMC3538128

Garcia-Fernandez, J., García-Velasco, J.A. (2020). Endometriosis and reproduction: What we have learned. Yale J. Biol. Med., 93 (4), 571-577. PMID: 33005121; PMCID: PMC7513434

Lessey, B.A., Kim, J.J. (2017). Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why. Fertil. Steril., 108 (1), 19-27. DOI: 10.1016/j.fertnstert. 2017.05.031. Epub 2017 Jun 14. PMID: 28602477; PMCID: PMC5629018

Dinsdale, N.L., & Crespi, B. J. (2021). Endometriosis and polycystic ovary syndrome are diametric disorders. Evol. Appl., 14, 1693-1715. https://doi.org/10.1111/eva.13244

Kofinas, J.D., Elias, R.T. (2014). Follicle-sti­mulating hormone/luteinizing hormone ratio as an inde­pendent predictor of response to controlled ovarian stimulation. Womens Health (Lond), (5), 505-509. DOI: 10.2217/whe.14.31. Epub 2014 May 8. PMID: 24807379

Huang, L., Chen, M., Long, L., Tuo, Y., Wang, Z., Zhou, C., Li, Y. (2021). Low basal serum testosterone level is detrimental to the embryo implantation in the patients with severe endometriosis. J. Obstet. Gynaecol. Res., 47 (6), 2166-2174. DOI: 10.1111/jog.14791. Epub 2021 Apr 5. PMID: 33819929

Kulinska, K.I., Andrusiewicz, M., Dera-Szy­ma­nowska, A., Billert, M., Skrzypski, M., Szymanowski, K., Nowak-Markwitz, E., et al. (2021). Phoenixin as a new target in the development of strategies for endometriosis diagnosis and treatment. Biomedicines, 9 (10), 1427. DOI: 10.3390/biomedicines9101427. PMID: 34680544; PMCID: PMC8533597

de Ziegler, D., Pirtea, P., Carbonnel, M., Poulain, M., Cicinelli, E., Bulletti, C., Kostaras, K., et al. (2019). Assisted reproduction in endometriosis. Best Pract. Res. Clin. Endocrinol. Metab., 33 (1), 47-59. DOI: 10.1016/j.beem.2018.10.001. Epub 2018 Nov 3. PMID: 30503728



How to Cite

Хміль, С. В., & Підгайна, І. Я. (2023). EVALUATION OF THE HORMONAL BACKGROUND OF WOMEN WITH ENDOMETRIOSIS-ASSOCIATED INFERTILITY. Medical and Clinical Chemistry, (4), 101–106. https://doi.org/10.11603/mcch.2410-681X.2022.i4.13580